首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Identification of relevant hub genes for early intervention at gene coexpression modules with altered predicted expression in schizophrenia
【24h】

Identification of relevant hub genes for early intervention at gene coexpression modules with altered predicted expression in schizophrenia

机译:在精神分裂症中改变预测表达的基因共抑制模块早期干预相关枢纽基因的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Genetic risk for schizophrenia is due to the joint effect of multiple genes acting mainly at two different processes, prenatal/perinatal neurodevelopment and adolescence/early adulthood synapse maturation. Identification of important genes at the second process is of relevance for early intervention. The aim of this work was to identify gene co-expression modules with altered expression in schizophrenia during adolescence/early adulthood. To this goal, we predicted frontal cortex gene expression in one discovery sample, the largest GWAS of schizophrenia from the Psychiatric Genomics Consortium, using S-prediXcan, and in one target sample, consisting of 625 schizophrenic patients and 819 controls from Spain, using prediXcan. Prediction models were trained on GTEx frontal cortex expression dataset. In parallel, we identified brain co-expression modules from BrainSpan using WGCNA. Then, we estimated polygenic risk scores based on predicted expression (PE-PRS) for each coexpression module in the target sample, based on PE-PRS model from the discovery sample. This analysis led to the identification of a module with mainly adolescence/adulthood expression whose PE-PRS was significantly associated with schizophrenia. The module was significantly enriched in synaptic processes. Several hub genes at this module are drugabble, according to the drug-gene interaction database, and/or involved in synaptic transmission, such as the voltage-gated ion channels SCN2B and KCNAB2, the calcium calmodulin kinases CAMK2A and CAMK1G, or genes involved in synaptic vesicle cycle, such as DNM1, or SYNGR1. Therefore, identification of this module may be the first step in patient stratification based on biology, as well as in drug design and drug repurposing efforts.
机译:精神分裂症的遗传风险是由于多种基因的关节作用,主要是两种不同的过程,产前/围产期神经发育和青春期/早期的Adulthood Synapse成熟。第二个过程的重要基因的鉴定与早期干预有关。这项工作的目的是鉴定基因共表达模块,在青春期/早期的青春期期间有精神分裂症的表达改变。为了实现这一目标,我们预测了一个发现样品中的前皮质基因表达,来自精神科学基因组学联盟,使用S-Predixcan和一个目标样品,由Predixcan组成的625名精神分裂症患者和819名控件组成。预测模型在GTEX Frontal Cortex表达式数据集上培训。并行地,我们使用WGCNA识别来自BRINSPAN的脑共同表达模块。然后,我们基于来自发现样本的PE-PRS模型,基于目标样本中的每个共抑制模块的预测表达式(PE-PRS)估计了多基因风险评分。该分析导致主要具有过青春期/成年表达的模块,其PE-PRS与精神分裂症显着相关。该模块在突触过程中显着富集。根据药物基因相互作用数据库和/或参与突触离子通道SCN2B和KCNAB2,根据药物 - 基因相互作用数据库和/或涉及突触式离子通道SCN2B和KCNAB2,钙钙调蛋白激酶CAMK2A和CAMK1G或所涉及基因突触囊泡循环,如DNM1或SYNGR1。因此,该模块的鉴定可以是基于生物学的患者分层的第一步,以及药物设计和药物重新施用努力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号